Back to Search
Start Over
Using a clinicopathologic and gene expression (CP-GEP) model to identify stage I-II melanoma patients at risk for disease relapse.
- Source :
- European Journal of Surgical Oncology; Feb2023, Vol. 49 Issue 2, pe34-e34, 1p
- Publication Year :
- 2023
- Subjects :
- DISEASE relapse
GENE expression
CLINICAL pathology
MELANOMA
Subjects
Details
- Language :
- English
- ISSN :
- 07487983
- Volume :
- 49
- Issue :
- 2
- Database :
- Supplemental Index
- Journal :
- European Journal of Surgical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 162010917
- Full Text :
- https://doi.org/10.1016/j.ejso.2022.11.138